Australian biotech market today 26.03.09
Thursday, 26 March, 2009
The pharma and biotech index is up 2.35 per cent at 3.00pm on a generally positive day for the share market.
Cochlear (ASX:COH) is up 63c and CSL (ASX:CSL) is up 79c, while Resmed (ASX:RMD) has had smaller gains.
Progen (ASX:PGL) is up a bit on news of its share buyback. Alchemia (ASX:ACL) is up a touch to 29c and Genera Biosystems (ASX:GBI) is up 5c, both on the back of new share options.
Peplin (ASX:PLI) is up 4c on small trades while Sonic Healthcare (ASX:SHL) is up a cent to $11.32.
ChemGenex (ASX:CXS) is down slightly, as is Novogen (ASX:NRT).
Inhaled form of blood thinner treats serious COVID infections
Heparin has traditionally been injected and used to treat blood clots, but the new study tested...
Next-gen therapies could treat high-grade gliomas
Government funding will enable researchers to test a suite of next-generation therapies they have...
Bacteriophage cocktail to combat superbugs
Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...
